Blinatumomab addition to chemotherapy significantly improves survival and reduces relapse in pediatric B-cell acute ...

An immunomodulatory vaccine advancing to phase 3 trials highlights the evolving role of immune system recalibration in cancer treatment. From immunotherapy breakthroughs to early-stage scientific ...

Our top content coverage from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 highlighted ...

Ruxolitinib cream demonstrated favorable safety and efficacy in pediatric atopic dermatitis, highlighting JAK inhibitors' ...

For those and other reasons, targeted oral therapies like Bruton tyrosine kinase inhibitors (BTKis) and the BCL-2 inhibitor ...

The SERENA-6 trial shows a 54% reduced risk of death with camizestrant, with a median PFS of 16.6 months versus 9.2 months ...

Nerandomilast, a novel anti-fibrotic agent with improved tolerability and a dual antifibrotic/immunomodulatory mechanism, ...

AI's role in early cancer detection and patient outcome improvement is significant, with tools evaluated for utility and ...

Guidelines statement on biosimilars was revised to include any appropriate biosimilar for a therapy vs focusing on rituximab.

Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...

A central challenge in relapsed/refractory follicular lymphoma is determining a treatment sequence that maximizes current ...

The ZENITH trial showed sotatercept significantly reduced death, transplant, or hospitalization risk in advanced PAH, leading ...